Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vivacelle Bio

Request full access

Pre-clinical stage life science company focused on bringing to market a new paradigm in resuscitation fluids

Chicago, United StatesFounded 2013Biotech & Life Sciences

About Vivacelle Bio

Vivacelle Bio, Inc. is a developmental stage biotechnology company focused on creating innovative products utilizing nanoparticle technology. The company's primary product, VBI 1, is a colloid non-blood volume expander designed to treat hypovolemia, a condition characterized by inadequate fluid volume in blood vessels. Hypovolemia can result from acute blood loss due to trauma, surgery, shock, sepsis, severe diarrhea, and burns, leading to cellular injury and death if untreated. VBI 1 has shown to be two to three times more effective and safer than standard treatments in animal studies. The FDA granted clearance for a phase IIa clinical trial of VBI 1 on February 1, 2019.

Vivacelle Bio operates in the biotechnology and healthcare market, primarily targeting medical institutions and healthcare providers dealing with emergency and critical care situations. The company's business model revolves around the development and commercialization of its proprietary nanoparticle-based treatments. Revenue generation is expected through the successful clinical trials, regulatory approvals, and subsequent sales and licensing of its products.

Source: Dealroom company data

At a glance

Status
Operational
Employees
17
Open positions
None listed
Dealroom signal
80.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2024 $20M $80M 2Flo Ventures (Chicago) ↗
SERIES AEquity / VC Aug 2018 $1.2M $4.8M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Vivacelle Bio website traffic

Latest recorded traffic for Vivacelle Bio is 420 monthly website visits, down 48.8% over the last three months. Vivacelle Bio's team grew 13.3% over the past year.

Latest monthly visits420 3-month web change-48.8% 1-year team growth+13.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vivacelle Bio in the Chicago ecosystem

Live from Dealroom

The Vivacelle Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • 2Flo Ventures (Chicago)

Other known investors1 additional known investor

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vivacelle Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vivacelle Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.